Thai Health Experts Get WHO Help To Overcome Vaccine Delay
This article was originally published in PharmAsia News
Executive Summary
Thailand's Government Pharmaceutical Organization says the World Health Organization is helping it deal with problems in developing an H1N1 flu vaccine. The Thai effort has encountered a hurdle in obtaining more than a low yield from the viruses it has been growing in eggs. The WHO is conferring with the GPO and the Public Health Ministry on how to improve the yield. The first trial of a vaccine in Thailand, originally scheduled to begin Sept. 4, now faces a two-month delay because of the problems. (Click here for more
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.